How have ATRI shares performed in 2024?

Atrion's stock was trading at $378.79 at the beginning of the year. Since then, ATRI stock has increased by 7.9% and is now trading at $408.70. View the best growth stocks for 2024 here .

When is Atrion's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 13th 2024. View our ATRI earnings forecast .

How were Atrion's earnings last quarter?

Atrion Co. (NASDAQ:ATRI) issued its earnings results on Thursday, February, 29th. The medical instruments supplier reported $3.65 earnings per share for the quarter. The medical instruments supplier earned $43.58 million during the quarter. Atrion had a net margin of 11.46% and a trailing twelve-month return on equity of 8.07%.

How often does Atrion pay dividends? What is the dividend yield for Atrion?

Atrion declared a quarterly dividend on Tuesday, February 27th. Stockholders of record on Friday, March 15th will be given a dividend of $2.20 per share on Friday, March 29th. This represents a $8.80 annualized dividend and a yield of 2.15%. The ex-dividend date of this dividend is Thursday, March 14th. Read our dividend analysis for ATRI .

Is Atrion a good dividend stock?

Atrion (NASDAQ:ATRI) pays an annual dividend of $8.80 per share and currently has a dividend yield of 2.20%. The company has been increasing its dividend for 21 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 79.78%. Payout ratios above 75% are not desirable because they may not be sustainable. Read our dividend analysis for ATRI .

What ETFs hold Atrion's stock?

ETFs with the largest weight of Atrion (NASDAQ:ATRI) stock in their portfolio include ProShares Russell 2000 Dividend Growers ETF (SMDV) . Invesco Nasdaq Future Gen 200 ETF (QQQS) .

What is David A. Batta's approval rating as Atrion's CEO?

1 employees have rated Atrion Chief Executive Officer David A. Batta on Glassdoor.com . David A. Batta has an approval rating of 100% among the company's employees. This puts David A. Batta in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. 100.0% of employees surveyed would recommend working at Atrion to a friend.

What other stocks do shareholders of Atrion own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Atrion investors own include International Paper (IP) , AT&T (T) , WestRock (WRK) , AbbVie (ABBV) , Caterpillar (CAT) , Eastman Chemical (EMN) , Gilead Sciences (GILD) , Altria Group (MO) , Pfizer (PFE) and Philip Morris International (PM) .

How do I buy shares of Atrion?

Shares of ATRI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:ATRI

Atrion (ATRI) Stock Price, News & Analysis

→ Can't believe it's happening again (From Manward Press) (Ad)

Free ATRI Stock Alerts

$408.70

+10.02 (+2.51%)

(As of 11:11 AM ET)

Compare

Today's Range: $398.80
▼
$408.70
50-Day Range: $335.88
▼
$463.55
52-Week Range: $274.98
▼
$670.00

Volume: 16,416 shs
Average Volume: 16,446 shs
Market Capitalization: $719.31 million

P/E Ratio: 37.05
Dividend Yield: 2.15%
Price Target: N/A

Get Atrion alerts:

Atrion MarketRank™ Stock Analysis

Analyst Rating: N/A
Upside/Downside: N/A
Short Interest: Bearish
7.13% of Float Sold Short
Dividend Strength: Moderate
Based on Four Factors
Sustainability: N/A
News Sentiment: 0.72
Based on 4 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: N/A

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.63 out of 5 stars

Medical Sector

695th out of 930 stocks

Surgical & Medical Instruments Industry

75th out of 99 stocks

N/A

Analyst's Opinion

Consensus Rating
There is not enough analysis data for Atrion.

1.0

Short Interest

Percentage of Shares Shorted
7.13% of the float of Atrion has been sold short.
Short Interest Ratio / Days to Cover
Atrion has a short interest ratio ("days to cover") of 6.5.
Change versus previous month
Short interest in Atrion has recently increased by 4.72%, indicating that investor sentiment is decreasing.

2.5

Dividend Strength

Dividend Yield
Atrion pays a meaningful dividend of 2.20%, higher than the bottom 25% of all stocks that pay dividends.
Dividend Growth
Atrion has been increasing its dividend for 21 years.
Dividend Coverage
The dividend payout ratio of Atrion is 79.78%. Payout ratios above 75% are not desirable because they may not be sustainable.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for ATRI.

2.6

News and Social Media Coverage

News Sentiment
Atrion has a news sentiment score of 0.72. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
News Coverage This Week
MarketBeat has tracked 4 news articles for Atrion this week, compared to 1 article on an average week.
Search Interest
3 people have searched for ATRI on MarketBeat in the last 30 days.

3.3

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Atrion insiders have not sold or bought any company stock.
Percentage Held by Insiders
22.70% of the stock of Atrion is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
66.19% of the stock of Atrion is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.3

Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Atrion is 37.05, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 135.01.
Price to Earnings Ratio vs. Sector
The P/E ratio of Atrion is 37.05, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 184.89.
Price to Book Value per Share Ratio
Atrion has a P/B Ratio of 2.96. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad Manward Press

Can't believe it's happening again

One of the single most unique and powerful events in the markets is coming in the next two months. It’s scheduled for April 22, 2024. But investors are moving now to get ahead of what’s coming… driving up prices of one asset dramatically. And you should do the same.

We explain how this event works in full right here.

About Atrion Stock (NASDAQ:ATRI)

Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmic applications in the United States, Canada, Europe, and internationally. The company's fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. Its cardiovascular products comprise Myocardial Protection System that delivers fluids and medications, and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. The company's ophthalmic products consist of a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. It manufactures products for safe needle and scalpel blade containment; inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; and one-way and two-way pressure relief valves that protect sensitive electronics and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales force, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.

ATRI Stock Price History

30 days | 90 days | 365 days | Advanced Chart

ATRI Stock News Headlines

April 13, 2024 | americanbankingnews.com

Atrion (NASDAQ:ATRI) Sees Unusually-High Trading Volume

April 11, 2024 | theglobeandmail.com

3 Small Cap Dividend Stocks With Income And Growth

April 16, 2024 | Manward Press (Ad)

Can't believe it's happening again

April 8, 2024 | americanbankingnews.com

Analyzing Atrion (NASDAQ:ATRI) & Assure (NASDAQ:IONM)

March 25, 2024 | finance.yahoo.com

Some Investors May Be Worried About Atrion's (NASDAQ:ATRI) Returns On Capital

March 24, 2024 | seekingalpha.com

Atrion Corporation Is Overvalued For The Direction Fundamentals Are Heading

March 13, 2024 | msn.com

Huntsville companies’ joint venture lands $910 million U.S. Army contract

March 2, 2024 | finance.yahoo.com

Atrion Full Year 2023 Earnings: EPS: US$11.02 (vs US$19.59 in FY 2022)

April 16, 2024 | Manward Press (Ad)

Can't believe it's happening again

March 1, 2024 | finanznachrichten.de

Atrion Corporation: Atrion Reports Fourth Quarter And Full Year 2023 Results

February 29, 2024 | finance.yahoo.com

Atrion Corp (ATRI) Faces Headwinds: Full Year Revenue and Net Income Decline

February 29, 2024 | globenewswire.com

Atrion Reports Fourth Quarter And Full Year 2023 Results

February 27, 2024 | globenewswire.com

Atrion Corporation Declares Quarterly Cash Dividend

February 21, 2024 | finance.yahoo.com

Plurilock Launches New Critical Services Offering to Enable Security and Resilience for Multinationals with Geopolitical Exposure

February 20, 2024 | wsj.com

Atrion Corp.

February 20, 2024 | finance.yahoo.com

Atrion Corporation (NASDAQ:ATRI) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?

January 24, 2024 | theglobeandmail.com

Plurilock Receives US$2.5 Million Cybersecurity Sale Order from U.S. Hospital System

January 23, 2024 | finance.yahoo.com

Atrion (NASDAQ:ATRI) investors are sitting on a loss of 54% if they invested five years ago

January 8, 2024 | markets.businessinsider.com

Top 3 Health Care Stocks That May Plunge In January

November 18, 2023 | finance.yahoo.com

Insider Buying: Atrion President & CEO Bought US$90k Of Shares

November 16, 2023 | seekingalpha.com

Atrion Corporation: A Curious But Concerning Selloff

November 13, 2023 | msn.com

Atrion declares $2.20 dividend

November 8, 2023 | morningstar.com

Atrion Corp ATRI

November 8, 2023 | finanznachrichten.de

Atrion Corporation: Atrion Reports Third Quarter 2023 Results

November 7, 2023 | msn.com

Atrion GAAP EPS of $1.67, revenue of $41.9M

November 7, 2023 | finance.yahoo.com

Atrion Reports Third Quarter 2023 Results

September 22, 2023 | benzinga.com

Board Member At This Health Care Company Buys $82K of Stock

See More Headlines

Receive ATRI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Atrion and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 2/29/2024
Ex-Dividend for 3/29 Dividend: 3/14/2024
Dividend Payable: 3/29/2024
Today: 4/16/2024
Next Earnings (Estimated): 5/13/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Surgical & medical instruments
Sub-Industry: Health Care Supplies
Current Symbol: NASDAQ:ATRI
CUSIP: 04990410
CIK: 701288
Web: www.atrioncorp.com
Phone: (972) 390-9800
Fax: 972-396-7581
Employees: 712
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): $11.03
Trailing P/E Ratio: 36.15
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $19.41 million
Net Margins: 11.46%
Pretax Margin: 13.21%
Return on Equity: 8.07%
Return on Assets: 7.37%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 9.09
Quick Ratio: 2.57

Sales & Book Value

Annual Sales: $169.33 million
Price / Sales: 4.14
Cash Flow: $19.58 per share
Price / Cash Flow: 20.36
Book Value: $138.02 per share
Price / Book: 2.89

Miscellaneous

Outstanding Shares: 1,760,000
Free Float: 1,360,000
Market Cap: $701.68 million
Optionable: Not Optionable
Beta: 0.60

(Almost) Everything You Need To Know About The EV Market

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

Mr. Emile A. Battat (Age 86)
Executive Chairman
Comp: $906.12k
Mr. David A. Battat (Age 54)
President & CEO
Comp: $1.54M
Ms. Cindy Ferguson (Age 48)
VP, CFO, Secretary & Treasurer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

ATRI Stock Analysis - Frequently Asked Questions

How have ATRI shares performed in 2024?: Atrion's stock was trading at $378.79 at the beginning of the year. Since then, ATRI stock has increased by 7.9% and is now trading at $408.70.
View the best growth stocks for 2024 here.
When is Atrion's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, May 13th 2024.
View our ATRI earnings forecast.
How were Atrion's earnings last quarter?: Atrion Co. (NASDAQ:ATRI) issued its earnings results on Thursday, February, 29th. The medical instruments supplier reported $3.65 earnings per share for the quarter. The medical instruments supplier earned $43.58 million during the quarter. Atrion had a net margin of 11.46% and a trailing twelve-month return on equity of 8.07%.
How often does Atrion pay dividends? What is the dividend yield for Atrion?: Atrion declared a quarterly dividend on Tuesday, February 27th. Stockholders of record on Friday, March 15th will be given a dividend of $2.20 per share on Friday, March 29th. This represents a $8.80 annualized dividend and a yield of 2.15%. The ex-dividend date of this dividend is Thursday, March 14th.
Read our dividend analysis for ATRI.
Is Atrion a good dividend stock?: Atrion (NASDAQ:ATRI) pays an annual dividend of $8.80 per share and currently has a dividend yield of 2.20%. The company has been increasing its dividend for 21 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 79.78%. Payout ratios above 75% are not desirable because they may not be sustainable.
Read our dividend analysis for ATRI.

What ETFs hold Atrion's stock?: ETFs with the largest weight of Atrion (NASDAQ:ATRI) stock in their portfolio include ProShares Russell 2000 Dividend Growers ETF (SMDV).Invesco Nasdaq Future Gen 200 ETF (QQQS).
What is David A. Batta's approval rating as Atrion's CEO?: 1 employees have rated Atrion Chief Executive Officer David A. Batta on Glassdoor.com. David A. Batta has an approval rating of 100% among the company's employees. This puts David A. Batta in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. 100.0% of employees surveyed would recommend working at Atrion to a friend.
What other stocks do shareholders of Atrion own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Atrion investors own include International Paper (IP), AT&T (T), WestRock (WRK), AbbVie (ABBV), Caterpillar (CAT), Eastman Chemical (EMN), Gilead Sciences (GILD), Altria Group (MO), Pfizer (PFE) and Philip Morris International (PM).
How do I buy shares of Atrion?: Shares of ATRI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:ATRI) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Atrion (ATRI) Stock Price, News & Analysis

Atrion MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

Company Ownership

Earnings and Valuation

About Atrion Stock (NASDAQ:ATRI)

ATRI Stock Price History

ATRI Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders & Institutions

ATRI Stock Analysis - Frequently Asked Questions

Overall MarketRank^™